Lung Institute
Dallas-based Lung Institute: Pioneers in regenerative medicine, offering innovative, minimally invasive stem cell therapies for debilitating lung disorders.
Founded
2013Dallas-based Lung Institute: Pioneers in regenerative medicine, offering innovative, minimally invasive stem cell therapies for debilitating lung disorders.
Founded in Dallas, the Lung Institute is a pioneering healthcare organization focused on regenerative medicine. Their core mission is to offer innovative, minimally invasive stem cell therapies to treat debilitating lung disorders such as chronic obstructive pulmonary disorder (COPD), pulmonary fibrosis, emphysema, and interstitial lung disease. The Lung Institute aims to improve patients' quality of life by providing more effective treatment options for these severe pulmonary conditions.
The Lung Institute has garnered global recognition through the expertise of its physicians and their dedicated practices. Notable achievements include advancements in stem cell therapy techniques that have significantly impacted patient outcomes. The organization has also attracted attention from leading investors in the healthcare sector, further solidifying its reputation as a leader in regenerative medicine. Through its innovative treatments, the Lung Institute has made a substantial impact on the lives of those suffering from chronic lung diseases.
Companies similar to Lung Institute include Pulmatrix, RhinoCyte, AlphaStem and Pulmonx.
Lung Institute was founded in 2013.
Lung Institute's headquarters is located in Tampa, FL, US.
Lung Institute's most recent funding round was for $232k (USD) in March 2015.
As of Mar 31, 2015, Lung Institute has raised a total of $232k (USD).
Lung Institute has 11 employees as of Feb 4, 2024.
AlphaStem
alpha-stim.com
